QUOTED. 27 February 2020. Michael Gibson.
Executive Summary
Apple and Johnson & Johnson are recruiting patients into Heartline, a 150,000-patient "virtual" randomized study to evaluate how the Apple watch can improve patient outcomes by reducing risk of stroke and detect atrial fibrillation early. See what Heartline's co-chair Michael Gibson of Harvard University said about it here.
“Heartline is a study that has the potential to fundamentally change our understanding of how digital health tools, like the ECG app and irregular rhythm notification feature on Apple Watch, could lead to earlier detection of [atrial fibrillation], helping patients understand and directly engage in their heart health, prompting potentially life-saving conversations with their doctors, and improving health outcomes.” – Michael Gibson, researcher, Harvard University
- Find out more: Apple and J&J Collaborate On Large Atrial Fibrillation Study
Click here for a free trial of Medtech Insight